Protara Therapeutics, Inc. - COM STK (TARA)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM STK
Shares, excl. options Q3 2024
10.4M
Holdings value Q3 2024
$19.1M
Value change Q3 2024
+$384K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
33
Number of buys Q3 2024
16
Number of sells Q3 2024
-14
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 10.4M $19.1M +$384K $1.83 33
2024 Q2 10.4M $22.2M +$12M $2.08 39
2024 Q1 4.57M $18.3M +$911K $4.01 35
2023 Q4 4.36M $8.17M -$1.26M $1.88 30
2023 Q3 5.12M $8.55M -$31.8K $1.67 31
2023 Q2 5.14M $12.3M -$1.13M $2.39 28
2023 Q1 5.5M $16.9M +$77.6K $3.13 28
2022 Q4 5.48M $14.7M -$481K $2.68 29
2022 Q3 5.66M $16.7M -$789K $2.96 26
2022 Q2 5.93M $18.4M -$2.06M $2.93 31
2022 Q1 6.5M $33.2M -$1.99M $5.11 34
2021 Q4 6.87M $46.5M +$3.84M $6.75 36
2021 Q3 6.31M $43.7M -$8.6M $6.92 36
2021 Q2 7.11M $69.3M -$22.9M $9.74 38
2021 Q1 8.53M $134M -$11.6M $15.74 49
2020 Q4 8.78M $212M -$5.83M $24.21 48
2020 Q3 9.28M $156M +$91.8M $16.83 44
2020 Q2 3.7M $108M +$108M $29.32 31